Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Collaboration with Mayo Clinic's Center for Individualized Medicine will investigate novel microbial solutions for improving health, including body weight
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Archer Daniels Midland Company (NYSE:ADM) today announced a collaboration with Mayo Clinic in personalized nutrition. The company will work with Mayo's Microbiome Program, led by Dr. Heidi Nelson, to investigate microbial solutions to improve health and wellness, initially focusing on the maintenance of healthy body weight.
"We are pleased to enter into this cutting-edge collaboration with Mayo Clinic to study the association of specific probiotics, prebiotics, and other nutrients with body weight," said Vikram Luthar, ADM's president, Bioactives. "Personalized nutrition is an important growth platform for ADM. Earlier this year, we acquired Biopolis, a leading player in health-promoting microbial technology. Now, by working with Mayo Clinic, we are further expanding our capabilities to develop personalized nutrition solutions to improve health and wellness, and bring these beneficial solutions directly to consumers."
The goal of the collaboration is to develop a personalized nutrition model that predicts the effects of probiotics, prebiotics and other metabolites, as well as other nutrients in microbiome shifts, for improving individual health. In the initial phase, ADM and Mayo Clinic will work to design a computational method for testing probiotics, metabolites, and other intervention strategies that promote the growth of gut microbes linked to healthy body weight. Additional projects are planned to leverage both organizations' strengths. Mayo Clinic will provide data analysis, modeling and gut microbiome expertise. ADM will bring expertise in food ingredients, strain development and genomics, as well as commercialization capabilities.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
About ADM
For more than a century, the people of Archer Daniels Midland Company (NYSE:ADM) have transformed crops into products that serve the vital needs of a growing world. Today, we're one of the world's largest agricultural processors and food ingredient providers, with approximately 32,000 employees serving customers in more than 160 countries. With a global value chain that includes approximately 500 crop procurement locations, 250 ingredient manufacturing facilities, 38 innovation centers and the world's premier crop transportation network, we connect the harvest to the home, making products for food, animal feed, industrial and energy uses. Learn more at www.adm.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170914005969/en/
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.